BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• BioCapital

  MaxCyte, Inc. To Present At The 2006 Mid-Atlantic BIO Conference

  October 2, 2006

   · 

  1 min read
• MBVax Bioscience Revives Century-Old ‘Coley’s Toxins’ Cancer Therapy

  October 2, 2006

   · 

  1 min read
• Policy

  FDA Issues Approvable Letter For Johnson and Johnson Pharmaceutical Research and Development, LLC (CA)'s Paliperidone ER For The Treatment Of Schizophrenia

  October 2, 2006

   · 

  3 min read
• Drug Development

  Biocryst Pharmaceuticals Announces Presentation Of Data Supporting Development Of Peramivir For Seasonal And Life-Threatening Influenza

  October 2, 2006

   · 

  7 min read
• Drug Development

  Roche Release: XELOX (Xeloda(R) + oxaliplatin) Shown To Be As Effective As Current Standard In The Treatment Of Advanced Colorectal Cancer For Progression-Free Survival

  October 2, 2006

   · 

  6 min read
• FDA

  Ipsen: EMEA’s Validation Of Febuxostat’s Marketing Authorization Application In The European Union

  October 2, 2006

   · 

  1 min read
• Policy

  Solvay SA Delays U.S. Filing For Psychosis Drug

  October 2, 2006

   · 

  1 min read
• Policy

  Alfacell Completes Non-Clinical Section Of Rolling NDA For Lead Anticancer Drug ONCONASE(R)

  October 2, 2006

   · 

  1 min read
• Anticus Corporation: Private Placement Completed

  October 2, 2006

   · 

  1 min read
• Policy

  Daiichi Sankyo, Inc. Subsidiary Applies For Additional Indication For Fentanyl Injection

  October 2, 2006

   · 

  1 min read